Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mayo Clinic Launches Biobank in Arizona, Expanding Diversity Research

Published: Tuesday, October 15, 2013
Last Updated: Tuesday, October 15, 2013
Bookmark and Share
Mayo Clinic biobank will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.

The Sangre por Salud Biobank is a collaboration among Mayo, Mountain Park Health Center and Arizona State University. Biobanks are an integral component of Mayo's Center for Individualized Medicine.

"We want to do everything we can to involve the Latino population in biomedical research so we can focus on their specific health issues and better represent an accurate sampling in our biobank," says Lawrence Mandarino, Ph.D., Mayo Clinic Biobank director in Arizona. "And while there's been a lack of access to research opportunities, there certainly isn't a lack of interest. People are willing to participate." Participants who are registered Mountain Park Health Center patients learn about the biobank from their clinical providers.

A goal of the biobank is to offer research opportunities to patients from Mountain Park Health Center, which operates several clinics in the greater Phoenix area. While the biobank will support all types of medical studies, a special emphasis will be given to projects on cardiometabolic risk and obesity — the single largest health burden to the population. Patients, ages 18 to 85 are enrolled regardless of their health background.

Patients may join the biobank only after being fully informed about the biobank procedure and purpose, and signing a consent document. The biobank allows researchers to use the genomic resource in the future, instead of seeking samples and consent for each project. The goal is to enroll 2,000 Mountain Park participants over the next four years, and already over 100 have enrolled.

"We're excited to collaborate with Mayo Clinic in this effort that will advance research and contribute to the wellbeing of our diverse patient population," says Davinder Singh, M.D., co-investigator from Mountain Park Health Center. "This collaboration allows us to identify appropriate interventions for medical problems diagnosed through the biobank enrollment."

Mayo Clinic Biobank has also expanded participation to the Mayo Clinic Health System, its group of primary care clinics and hospitals in Wisconsin, Minnesota and Iowa, with the first participants from clinics in LaCrosse and Onalaska, Wisconsin.

The Biobank began on Mayo's Rochester, Minn. campus in 2009. A Florida component added last year has an enrollment goal of 5,000. Nationally, the goal is to have 50,000 participants by 2016, including 5,000 from the Mayo Clinic Health System. Mayo's Biobank differs from most in that it not only collects biological samples for genomic studies, but it links that information to data from the participant's medical record.

Mayo Clinic's peer-reviewed medical journal, Mayo Clinic Proceedings, has just published two articles covering the evolution and research of the Mayo Clinic Biobank: The Mayo Clinic Biobank: A Building Block for Individualized Medicine by Janet E. Olson, Ph.D., et al, and Hospitalizations and Emergency Department Use in Mayo Clinic Biobank Participants Within the Employee and Community Health Medical Home by Paul Takahashi, M.D., M.P.H., et al.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Mayo, Baylor Collaborate
They aim to study genomic links to drug metabolism and other interactions which could be used to provide more tailored patient care.
Friday, May 15, 2015
Controlling iPS Cell Transformation: It’s in the Sugar
Researchers at Mayo Clinic show how cellular metabolism facilitates stem cell procurement from regular tissue.
Friday, September 02, 2011
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!